(Bloomberg) -- Moderna Inc. is broadening its testing of a vaccine for a leading infectious cause of birth defects after early-stage clinical results showed it induced immune responses in patients. A larger, mid-stage study will begin soon and could produce ...
from Google Alert - health https://ift.tt/34Bo7vz
via IFTTT
0 comments:
Post a Comment